195 related articles for article (PubMed ID: 33991970)
1. Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone.
Peisen F; Maurer M; Grosse U; Nikolaou K; Syha R; Artzner C; Bitzer M; Horger M; Grözinger G
Eur J Radiol; 2021 Jul; 140():109768. PubMed ID: 33991970
[TBL] [Abstract][Full Text] [Related]
2. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
3. Radiation exposure during TACE procedures using additional cone-beam CT (CBCT) for guidance: safety and precautions.
Jonczyk M; Collettini F; Geisel D; Schnapauff D; Böning G; Wieners G; Gebauer G
Acta Radiol; 2018 Nov; 59(11):1277-1284. PubMed ID: 29490465
[TBL] [Abstract][Full Text] [Related]
4. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: Impact of Embolic Density and Residual Tumor Perfusion on Tumor Recurrence and Survival.
Ruff C; Artzner C; Syha R; Grosse U; Hoffmann R; Bitzer M; Partovi S; Horger M; Nikolaou K; Grözinger G
Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1403-1413. PubMed ID: 34021375
[TBL] [Abstract][Full Text] [Related]
6. Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization.
Bannangkoon K; Hongsakul K; Tubtawee T
BMC Gastroenterol; 2021 Nov; 21(1):419. PubMed ID: 34749658
[TBL] [Abstract][Full Text] [Related]
7. C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Cancer Imaging; 2015 Dec; 15():22. PubMed ID: 26715200
[TBL] [Abstract][Full Text] [Related]
8. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
[TBL] [Abstract][Full Text] [Related]
9. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of transarterial chemoembolisation with cone-beam CT in patients with hepatocellular carcinoma within the Milan criteria: a retrospective cohort study.
Lee JH; Lee IJ; Kim HB; Park B; Kim BH; Park JW; Kim CM
Clin Radiol; 2019 May; 74(5):407.e19-407.e28. PubMed ID: 30837076
[TBL] [Abstract][Full Text] [Related]
11. Intraprocedural blood volume measurement using C-arm CT as a predictor for treatment response of malignant liver tumours undergoing repetitive transarterial chemoembolization (TACE).
Vogl TJ; Schaefer P; Lehnert T; Nour-Eldin NE; Ackermann H; Mbalisike E; Hammerstingl R; Eichler K; Zangos S; Naguib NN
Eur Radiol; 2016 Mar; 26(3):755-63. PubMed ID: 26123407
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma.
Yuan H; Li X; Tian X; Ji K; Liu F
Abdom Radiol (NY); 2020 Aug; 45(8):2585-2592. PubMed ID: 32107583
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
[TBL] [Abstract][Full Text] [Related]
14. Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion.
Li Z; Jiao D; Si G; Han X; Zhang W; Li Y; Zhou X; Liu J; Li J; Liu Z
Int J Hyperthermia; 2021; 38(1):428-436. PubMed ID: 33691589
[TBL] [Abstract][Full Text] [Related]
15. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
Rathmann N; Kara K; Budjan J; Henzler T; Smakic A; Schoenberg SO; Diehl SJ
Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
[TBL] [Abstract][Full Text] [Related]
16. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
Maschke SK; Werncke T; Klöckner R; Rodt T; Renne J; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
Abdom Radiol (NY); 2018 May; 43(5):1245-1253. PubMed ID: 28840307
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
[TBL] [Abstract][Full Text] [Related]
18. Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention.
Becker LS; Maschke SK; Dewald CLA; Meine TC; Winther HBM; Kirstein MM; Kloeckner R; Meyer BC; Wacker F; Hinrichs JB
Clin Radiol; 2021 Feb; 76(2):160.e27-160.e33. PubMed ID: 33028487
[TBL] [Abstract][Full Text] [Related]
19. Correlation between SACE (Subjective Angiographic Chemoembolization Endpoint) score and tumor response and its impact on survival after DEB-TACE in patients with hepatocellular carcinoma.
Habbel VSA; Zeile M; Stavrou GA; Wacker F; Brüning R; Oldhafer KJ; Rodt T
Abdom Radiol (NY); 2019 Oct; 44(10):3463-3479. PubMed ID: 31332502
[TBL] [Abstract][Full Text] [Related]
20. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]